Frost & Sullivan Release: Innovation Would Be the Best Method to Fight Generics' Primacy in the Latin American Cardiovascular Drugs Markets
BUENOS AIRES, Argentina--(BUSINESS WIRE)--Latin American countries, due to their desire to mimic the lifestyles of developed countries, are increasingly falling prey to cardiovascular diseases (CVDs). This situation is providing valuable opportunities to pharmaceutical companies to develop drugs that can reduce drug interactions and offer better efficacy and safety profile.